Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thought Technology is a private Canadian health technology and medical device company focused on biofeedback, neurofeedback, psychophysiological monitoring, and rehabilitation instrumentation. Founded in 1975 and headquartered in Montreal, the company develops hardware sensors, signal acquisition systems, and software used by psychologists, physiotherapists, physicians, researchers, and other clinicians. Its products are used in stress management, heart rate variability training, neurofeedback, pelvic floor and continence therapy, and muscle rehabilitation, including sEMG-triggered stimulation. The company also serves research, education, ergonomics, and sports performance markets through its Science Division and broader physiological monitoring portfolio. Rather than operating as a drug-development biotech, Thought Technology is a commercial-stage healthcare technology manufacturer with established global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thought Technology.